Please use this identifier to cite or link to this item: http://hdl.handle.net/1822/37138

TitleProteome signatures-how are they obtained and what do they teach us?
Author(s)Costa, João Pinto da
Carvalhais, Virgínia Maria Dinis
Ferreira, Rita
Amado, Francisco
Vilanova, Manuel
Cerca, Nuno
Vitorino, Rui
KeywordsProteome signatures
Biomarkers
Immunoproteomics
Proteomics
Issue dateSep-2015
PublisherSpringer
JournalApplied Microbiology and Biotechnology
CitationCarvalhais, V.; Pinto da Costa J; R, Ferreira; Amado F; Vilanova, M.; Cerca, Nuno; Vitorino, R., Proteome signatures-how are they obtained and what do they teach us?. Applied Microbiology and Biotechnology, 99(18), 7417-7431, 2015
Abstract(s)The dawn of a new Proteomics era, just over a decade ago, allowed for large-scale protein profiling studies that have been applied in the identification of distinctive molecular cell signatures. Proteomics provides a powerful approach for identifying and studying these multiple molecular markers in a vast array of biological systems, whether focusing on basic biological research, diagnosis, therapeutics, or systems biology. This is a continuously expanding field that relies on the combination of different methodologies and current advances, both technological and analytical, which have led to an explosion of protein signatures and biomarker candidates. But how are these biological markers obtained? And, most importantly, what can we learn from them? Herein, we briefly overview the currently available approaches for obtaining relevant information at the proteome level, while noting the current and future roles of both traditional and modern proteomics. Moreover, we provide some considerations on how the development of powerful and robust bioinformatics tools will greatly benefit high-throughput proteomics. Such strategies are of the utmost importance in the rapidly emerging field of immunoproteomics, which may play a key role in the identification of antigens with diagnostic and/or therapeutic potential and in the development of new vaccines. Finally, we consider the present limitations in the discovery of new signatures and biomarkers and speculate on how such hurdles may be overcome, while also offering a prospect for the next few years in what could be one of the most significant strategies in translational medicine research.
TypeArticle
URIhttp://hdl.handle.net/1822/37138
DOI10.1007/s00253-015-6795-7
ISSN0175-7598
e-ISSN1432-0614
Publisher versionhttp://link.springer.com/article/10.1007%2Fs00253-015-6795-7
Peer-Reviewedyes
AccessOpen access
Appears in Collections:CEB - Publicações em Revistas/Séries Internacionais / Publications in International Journals/Series

Files in This Item:
File Description SizeFormat 
document_22274_1.pdf624,85 kBAdobe PDFView/Open

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID